Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D09PKZ
|
|||
| Former ID |
DIB000693
|
|||
| Drug Name |
NM-9308
|
|||
| Synonyms |
Bikaciomab; Bikaciomab (AMD), NovelMed Therapeutics; Complement factor B inhibitor (age related maculardegeneration), NovelMed Therapeutics; Anti-factor B monoclonal antibody (age related macular degenration), NovelMed Therapeutics
Click to Show/Hide
|
|||
| Drug Type |
Antibody
|
|||
| Indication | Age-related macular degeneration [ICD-11: 9B75.0; ICD-9: 362.5] | Investigative | [1] | |
| Company |
NovelMed Therapeutics Inc
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Complement factor B (CFB) | Target Info | . | [1] |
| KEGG Pathway | Complement and coagulation cascades | |||
| Staphylococcus aureus infection | ||||
| NetPath Pathway | TGF_beta_Receptor Signaling Pathway | |||
| Reactome | Alternative complement activation | |||
| Activation of C3 and C5 | ||||
| Regulation of Complement cascade | ||||
| WikiPathways | Complement and Coagulation Cascades | |||
| Human Complement System | ||||
| Complement cascade | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 2339). | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.